Obstacles and opportunities in Alzheimer's clinical trial recruitment.
The 2012 National Plan to Address Alzheimer's Disease set an ambitious goal: to both prevent and effectively treat Alzheimer's disease by 2025. To reach this goal, tens of thousands of volunteers will be needed to participate in clinical trials to test promising new interventions and therapies. To mobilize these volunteers and their health care providers to participate in future clinical trials, it will be necessary to achieve a better understanding of the barriers keeping people from participating in Alzheimer's research; form innovative partnerships among researchers, health care and social service providers, and the public; and develop more-effective outreach strategies. In this article we explore recruitment issues, including those unique to Alzheimer's studies, and we suggest concrete steps such as establishing a structured consortium linking all of the registries of Alzheimer's trials and establishing new partnerships with community and local organizations that can build trust and understanding among patients, caregivers, and providers.
Jennifer L
JL
Watson
Laurie
L
Ryan
Nina
N
Silverberg
Vicky
V
Cahan
Marie A
MA
Bernard
D000544:Alzheimer Disease / Q000517:prevention & control / Q000628:therapy*; D058070:Asymptomatic Diseases; D002986:Clinical Trials as Topic / Q000379:methods*; D006801:Humans; D008913:Minority Groups; D018579:Patient Selection; D058007:Physicians, Primary Care; D012042:Registries
Alzheimer’s; Clinical trials; Recruitment